Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1980 Feb;55(2):118–123. doi: 10.1136/adc.55.2.118

Infection during remission induction in childhood leukaemia

Judith M Chessells, Alison D Leiper
PMCID: PMC1626674  PMID: 6929664

Abstract

We have analysed our experience in the management of suspected infection in a group of 221 children with acute leukaemia undergoing induction of first remission. Patients with suspected infection received early empirical antibiotic therapy with cephalothin and gentamicin pending results of bacteriological investigations. Infection occurred in 17% of children with acute lymphoblastic leukaemia (ALL) whose initial treatment comprised prednisolone and vincristine, and was serious in 6·5%. 27% of children with ALL treated with intensive induction had infections which were serious in 20%; the figures for children with acute myeloblastic leukaemia (AML) were 49% and 22% respectively. The organisms responsible for most infections were Pseudomonas aeruginosa and Staphylococcus aureus; the former being most often associated with bacteraemia. One child (0·5%) died from infection.

We conclude that with the use of early empirical antibiotic therapy, and granulocytes when appropriate, infection is no longer a major cause of death during remission induction. No special precautions are necessary to prevent its acquisition in most cases of ALL. In patients receiving early intensive treatment, including those with AML, measures designed to prevent acquisition of infection may reduce morbidity and enable the use of more effective chemotherapy.

Full text

PDF
120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chessells J. M., Cornbleet M. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL). Med Pediatr Oncol. 1979;6(4):359–365. doi: 10.1002/mpo.2950060413. [DOI] [PubMed] [Google Scholar]
  2. Cornbleet M. A., Chessells J. M. Bone-marrow relapse in acute lymphoblastic leukaemia in childhood. Br Med J. 1978 Jul 8;2(6130):104–106. doi: 10.1136/bmj.2.6130.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Enno A., Catovsky D., Darrell J., Goldman J. M., Hows J., Galton D. A. Co-trimoxazole for prevention of infection in acute leukaemia. Lancet. 1978 Aug 19;2(8086):395–397. doi: 10.1016/s0140-6736(78)91865-2. [DOI] [PubMed] [Google Scholar]
  4. Fillastre J. P., Laumonier R., Humbert G., Dubois D., Metayer J., Delpech A., Leroy J., Robert M. Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J. 1973 May 19;2(5863):396–397. doi: 10.1136/bmj.2.5863.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Graw R. G., Jr, Herzig G., Perry S., Henderson E. S. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med. 1972 Aug 24;287(8):367–371. doi: 10.1056/NEJM197208242870801. [DOI] [PubMed] [Google Scholar]
  6. Hughes W. T., Kuhn S., Chaudhary S., Feldman S., Verzosa M., Aur R. J., Pratt C., George S. L. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1977 Dec 29;297(26):1419–1426. doi: 10.1056/NEJM197712292972602. [DOI] [PubMed] [Google Scholar]
  7. Hughes W. T., Smith D. R. Infection during induction of remission in acute lymphocytic leukemia. Cancer. 1973 Apr;31(4):1008–1014. doi: 10.1002/1097-0142(197304)31:4<1008::aid-cncr2820310434>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  8. Johnston P. G., Hardisty R. M., Kay H. E., Smith P. G. Myelosuppressive effect of colaspase (L-asparaginase) in initial treatment of acute lymphoblastic leukaemia. Br Med J. 1974 Jul 13;3(5923):81–83. doi: 10.1136/bmj.3.5923.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lowenthal R. M., Grossman L., Goldman J. M., Storring R. A., Buskard N. A., Park D. S., Murphy B. C., Spiers A. S., Galton D. A. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet. 1975 Feb 15;1(7903):353–358. doi: 10.1016/s0140-6736(75)91276-3. [DOI] [PubMed] [Google Scholar]
  10. Rodriguez V., Bodey G. P., Freireich E. J., McCredie K. B., Gutterman J. U., Keating M. J., Smith T. L., Gehan E. A. Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore) 1978 May;57(3):253–266. doi: 10.1097/00005792-197805000-00005. [DOI] [PubMed] [Google Scholar]
  11. Rodriguez V., Burgess M., Bodey G. P. Management of fever of unknown origin in patients with neoplasms and neutropenia. Cancer. 1973 Oct;32(4):1007–1012. doi: 10.1002/1097-0142(197310)32:4<1007::aid-cncr2820320437>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  12. Simone J. V. Factors that influence haematological remission duration in acute lymphocytic leukaemia. Br J Haematol. 1976 Apr;32(4):465–472. doi: 10.1111/j.1365-2141.1976.tb00950.x. [DOI] [PubMed] [Google Scholar]
  13. Smith I. E., Powles R., Clink H. M., Jameson B., Kay H. E., McElwain T. J. Early deaths in acute myelogenous leukemia. Cancer. 1977 Apr;39(4):1710–1714. doi: 10.1002/1097-0142(197704)39:4<1710::aid-cncr2820390448>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  14. Storring R. A., Jameson B., McElwain T. J., Wiltshaw E. Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet. 1977 Oct 22;2(8043):837–840. doi: 10.1016/s0140-6736(77)90779-6. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES